drugset / Trial / NCT01505491
Pharmacokinetics and Safety Study of BI 695501 in Healthy Subjects
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial will investigate the pharmacokinetics, safety and tolerability of BI 695501 and to establish pharmacokinetic equivalence of BI 695501 to adalimumab.
Timeline
- Start
- 2011-12-01
- Primary completion
- 2012-07-01
- Completion
- 2012-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Adalimumab | Monoclonal antibody | 40 mg | Subcutaneous |
| Subject | BI 695501 | Monoclonal antibody | — | Subcutaneous |
Indications
No indication recorded.